Standard
Mount Sinai Breakthrough Reveals How APOE4 Drives Brain Damage and Offers New Path to Treatment
Researchers at the Icahn School of Medicine at Mount Sinai have unveiled critical new insights into how APOE4—the most significant genetic risk factor for Alzheimer’s disease—actively dismantles the brain’s vascular health and disrupts cellular waste disposal. Published in two high-impact studies in Cell and Cell Stem Cell, the findings challenge the long-standing belief that vascular…
